Introduction
Leading pharmaceutical company enters agreement to acquire Organon in all cash deal valued at US$11.75 billion, subject to approvals and expected closing in early 2027.
Share price movement of Sun Pharma
On April 27, 2026, Sun Pharmaceutical Industries Ltd opened at ₹1,632.50, up 0.78% from its previous close of ₹1,619.95. The stock reached a high of ₹1,766.65 (9.06%) and a low of ₹1,621.00. By 11:05 AM, it traded at ₹1,730.80, a 6.84% increase, with a market cap of ₹4,15,315.10 crore.
Sun Pharma to acquire Organon
Sun Pharmaceutical Industries Limited announced agreement to acquire Organon for US$14.00 per share in an all cash deal, valuing Organon at enterprise value of US$11.75 billion.
Organon is a global healthcare company with more than 70 products across women’s health and general medicines, operating in over 140 countries with key markets including United States and Europe.
The acquisition aligns with Sun Pharma strategy to expand innovative medicines and enter biosimilars, creating a stronger global pharmaceutical platform with broader portfolio and enhanced geographic presence.
The transaction has board approvals from both companies and is expected to close in early 2027, subject to regulatory approvals and Organon stockholder approval conditions.
Stock performance of Sun Pharma for period of 1 week, 6 months, and 1 year
Sun Pharmaceutical Industries Ltd delivered a 1-week return of -2.89%, a 6-month return of -5.57%, and a 1-year return of -9.34%.
Also Read: HCC wins ₹2,917 crore CIDCO water infrastructure project
Shareholding pattern of Sun Pharma
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
| Promoter | 54.50% | 54.50% | 54.50% |
| FII | 15.90% | 16.10% | 16.60% |
| DII | 21.10% | 20.80% | 20.20% |
| Public | 8.50% | 8.60% | 8.70% |
About Sun Pharma
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) is a global specialty generics company with presence in innovative medicines, generics and consumer healthcare, serving over 100 countries worldwide.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Sun Pharmaceutical Industries Ltd share price rising today?
A: Sun Pharmaceutical Industries Ltd share price increased after announcing acquisition of Organon in all cash deal valued at US$11.75 billion.
Q: What is Sun Pharmaceutical Industries Ltd’s main business focus?
A: Sun Pharmaceutical Industries Ltd focuses on specialty generics, innovative medicines and consumer healthcare products across global markets including United States and emerging regions.
Q: What are the 52-week high and low of Sun Pharmaceutical Industries Ltd stock?
A: Sun Pharmaceutical Industries Ltd stock has a 52 week high of ₹1,850.95 and a 52 week low of ₹1,547.25.
